1. Home
  2. ORIS vs EVOK Comparison

ORIS vs EVOK Comparison

Compare ORIS & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ORIS
  • EVOK
  • Stock Information
  • Founded
  • ORIS 2014
  • EVOK 2007
  • Country
  • ORIS China
  • EVOK United States
  • Employees
  • ORIS N/A
  • EVOK N/A
  • Industry
  • ORIS Farming/Seeds/Milling
  • EVOK Biotechnology: Pharmaceutical Preparations
  • Sector
  • ORIS Consumer Staples
  • EVOK Health Care
  • Exchange
  • ORIS Nasdaq
  • EVOK Nasdaq
  • Market Cap
  • ORIS 5.3M
  • EVOK 5.4M
  • IPO Year
  • ORIS 2024
  • EVOK 2013
  • Fundamental
  • Price
  • ORIS $0.11
  • EVOK $5.21
  • Analyst Decision
  • ORIS
  • EVOK
  • Analyst Count
  • ORIS 0
  • EVOK 0
  • Target Price
  • ORIS N/A
  • EVOK N/A
  • AVG Volume (30 Days)
  • ORIS 63.9M
  • EVOK 437.4K
  • Earning Date
  • ORIS 01-01-0001
  • EVOK 08-14-2025
  • Dividend Yield
  • ORIS N/A
  • EVOK N/A
  • EPS Growth
  • ORIS N/A
  • EVOK N/A
  • EPS
  • ORIS 0.17
  • EVOK N/A
  • Revenue
  • ORIS $15,014,000.00
  • EVOK $12,794,859.00
  • Revenue This Year
  • ORIS N/A
  • EVOK $57.38
  • Revenue Next Year
  • ORIS N/A
  • EVOK $59.57
  • P/E Ratio
  • ORIS $0.68
  • EVOK N/A
  • Revenue Growth
  • ORIS N/A
  • EVOK 70.02
  • 52 Week Low
  • ORIS $0.08
  • EVOK $1.94
  • 52 Week High
  • ORIS $56.01
  • EVOK $12.32
  • Technical
  • Relative Strength Index (RSI)
  • ORIS 33.79
  • EVOK 50.12
  • Support Level
  • ORIS $0.11
  • EVOK $5.03
  • Resistance Level
  • ORIS $0.12
  • EVOK $5.57
  • Average True Range (ATR)
  • ORIS 0.01
  • EVOK 0.44
  • MACD
  • ORIS 0.02
  • EVOK -0.09
  • Stochastic Oscillator
  • ORIS 47.00
  • EVOK 11.17

About ORIS Oriental Rise Holdings Limited Ordinary Shares

Oriental Rise Holdings Ltd is an integrated supplier of tea products in China. It is principally engaged in the business of planting, cultivating, processing, and selling processed tea. The company currently produces and sells three categories of products: roughly processed white tea, roughly processed black tea, and refined tea. The company's business operations are vertically integrated, covering cultivation, processing of tea leaves, and the sale of tea products to tea business operators and end-user retail customers. Geographically, the company generates all of its revenue from its business in the People's Republic of China (the PRC).

About EVOK Evoke Pharma Inc.

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

Share on Social Networks: